Acutaas Chemicals Limited

rs,

Gujarat, India. May 14, 2023 To, The Listing Department, BSE LIMITED, Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai- 400 001 To, The Listing Department National Stock Exchange of India

19%

ve been able to deliver robust growth despite these challenges. Our full year total revenue grew by 19% YoY to Rs. 621cr. This was driven by Advance Pharmaceutical Intermediates business which grew stron

Rs. 621

e to deliver robust growth despite these challenges. Our full year total revenue grew by 19% YoY to Rs. 621cr. This was driven by Advance Pharmaceutical Intermediates business which grew strongly by 22% YoY.

22%

Rs. 621cr. This was driven by Advance Pharmaceutical Intermediates business which grew strongly by 22% YoY. We have used this challenging year to create various growth drivers for the coming years. One

55%

ate you on these once they reach certain milestones. I am also pleased to share the acquisition of 55% stake in Baba Fine Chemicals (BFC), a leading speciality chemicals company supplying products to th

Rs. 1,864

. Overall, I am confident of continuing the strong growth momentum in FY24.” Revenue for Q4FY23 Rs. 1,864 mn 29.8% YoY EBITDA for Q4FY23 Rs. 408 mn 58.3% YoY PBT for Q4FY23 Rs. 366 mn 64.5% YoY

29.8%

am confident of continuing the strong growth momentum in FY24.” Revenue for Q4FY23 Rs. 1,864 mn 29.8% YoY EBITDA for Q4FY23 Rs. 408 mn 58.3% YoY PBT for Q4FY23 Rs. 366 mn 64.5% YoY 4 Q4FY2

Rs. 408

trong growth momentum in FY24.” Revenue for Q4FY23 Rs. 1,864 mn 29.8% YoY EBITDA for Q4FY23 Rs. 408 mn 58.3% YoY PBT for Q4FY23 Rs. 366 mn 64.5% YoY 4 Q4FY23 Earnings Highlights Financial Hig

58.3%

h momentum in FY24.” Revenue for Q4FY23 Rs. 1,864 mn 29.8% YoY EBITDA for Q4FY23 Rs. 408 mn 58.3% YoY PBT for Q4FY23 Rs. 366 mn 64.5% YoY 4 Q4FY23 Earnings Highlights Financial Highlights

Rs. 366

for Q4FY23 Rs. 1,864 mn 29.8% YoY EBITDA for Q4FY23 Rs. 408 mn 58.3% YoY PBT for Q4FY23 Rs. 366 mn 64.5% YoY 4 Q4FY23 Earnings Highlights Financial Highlights Q4FY23 Highlights: ✓ Revenue fr

64.5%

Rs. 1,864 mn 29.8% YoY EBITDA for Q4FY23 Rs. 408 mn 58.3% YoY PBT for Q4FY23 Rs. 366 mn 64.5% YoY 4 Q4FY23 Earnings Highlights Financial Highlights Q4FY23 Highlights: ✓ Revenue from opera

22.3%

Revenue from operations for Q4FY23 grew by 29.8% YoY to Rs. 1,864 mn; Sequentially revenue grew by 22.3% ✓ The Gross margin for the quarter was at 43.6% as compared to 44.1% in Q4FY22 and 46% in Q3FY23.

“CAPEX – Funding The Capex will be funded through a mix of General Corporate funds of IPO proceeds, internal accruals, and debt.”

“Currently, the old plant at Ankleshwar is being demolished and the new plant will be built on this site.”

“The acquisition will be effective from 01st April 2023 Purchase Agreement signed on 22nd April 2023 with listed Condition Precedents (CP) & Condition Subsequent (CS) The consideration of Rs.”

YoY Growth

2

Social

1

Governance

1

For more information please contact

1

YoY Growth

34% 8% 1,600 1,190 Advance Intermediates EBITDA & EBITDA Margin (Rs Mn) 240 260 Chemicals PAT (Rs Mn) EBITDA EBITDA Margin PAT PAT Margin 450 400 350 300 250 200 150 100 18.0% 258 Q4FY22 21.9% 408 Q4FY23 290 280 270 260 250 240 230 220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 23.0% 21.0% 19.0% 17.0% 15.0% 13.0% 11.0% 9.0% 7.0% 5.0% 14.8% 14.6% 213 Q4FY22 272 Q4FY23 19.0% 17.0% 15.0% 13.0% 11.0% 9.0% 7.0% 5.0% 30% 1,860 1,430 Total EPS EPS 6.2 Q4FY22 7.5 Q4FY23 7 Financial performance – FY23 Revenue from Operations (Rs Mn) FY22 FY23

YoY Growth

22% 3% 5,180 4,241 Advance Intermediates EBITDA & EBITDA Margin (Rs Mn) EBITDA EBITDA Margin 20.2% 19.9% 1,052 FY22 1,227 FY23 1,300 1,100 900 700 500 300 100 960 990 Chemicals PAT (Rs Mn) PAT PAT Margin 13.8% 13.5% 719 FY22 833 FY23 15.0% 14.0% 13.0% 12.0% 11.0% 10.0% 9.0% 8.0% 7.0% 6.0% 5.0% 21.0% 19.0% 17.0% 15.0% 13.0% 11.0% 9.0% 7.0% 5.0% 860 850 840 830 820 810 800 790 780 770 760 750 740 730 720 710 700 690 680 670 660 650 640 630 620 610 600 590 580 570 560 550 540 530 520 510 500 490 480 470 460 450 440 430 420 410 400 19% 6,170 5,201 Total EPS EPS 21.0 FY22 22.9 FY23 8 P&L Statement for Q4FY23 & FY23 Particulars (Rs. Mn) Q4FY23 Q4FY22 YoY Q3FY23 QoQ Revenue from Operations 1,864 1,435 29.8% 1,524 22.3% COGS Gross Profit Gross Margin Employee benefits expenses Other expenses Total Expenses EBITDA EBITDA Margin Depreciation and amortization PBIT Finance costs Other Income PBT Tax Expense PAT PAT Margin 28.3% 1,051 813 802 634 43.6% 44.1% 115 290 110 266 1,456 1,178 16.1% 823 70

Social

➢ Zero Liquid Discharge based in-house effluent plant at Sachin Unit ➢ 80% of wastewater recycled ➢ Developing greenbelt in GIDC ➢ All the manufacturing units are ISO 9001:2015, ISO 14001:2015 certified ➢ Company’s Sachin Facility is SA 8000:2014 certified ➢ The SA8000® Standard is the leading social certification standard for factories and organizations across the globe** ➢ Occupational health and safety management system at Sachin Facility has been certified to be in compliance with ISO 45001:2018 standards by the Bureau Veritas Certification Holding SAS – UK Branch

Governance

✓ 50% of the board constitutes of independent directors ✓ Audit and NRC are headed by independent directors 1 2 3 42 Safe Harbor The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any investor should subscribe / purchase the company shares. The Company makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information contained herein. This presentation may include certain “forward looking statements”. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from these statements. Important fa

For more information please contact

Ami Organics Limited Ernst & Young Ekta Srivastava, Company Secretary & Compliance Officer Rahul Thakur Rahul.thakur@in.ey.com cs@amiorganics.com Advait Bhadekar Advait.bhadekar@in.ey.com © 2020 Ami Organics Limited, All Rights Reserved. 44